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It has been recognized since 1895 (1) that some gram-negative bacteria are sensitive 
to the lytic action of fresh serum, whereas others are highly serum resistant. In general, 
serum-resistant  organisms  are  more  pathogenic  than  serum-sensitive  bacteria  in 
animal  models  of  infection,  and  serum-resistant  organisms are  more  commonly 
isolated  from  the  bloodstream  of patients  with  gram-negative bacteremia  (2).  In 
attempts to define the basis of this important virulence factor, characteristics of the 
outer membrane of serum-sensitive and serum-resistant organisms have been analyzed 
and compared (3-5). The presence of a complete lipopolysaccharide (LPS) 1 (i.e., the 
smooth phenotype) is the characteristic most clearly associated with serum resistance. 
Rough bacteria lacking a complete LPS are almost invariably serum sensitive. 
The antibody and complement requirements for serum killing of bacteria also have 
been examined.  It has been shown  (6-8)  that  killing of gram-negative bacteria by 
serum requires the participation of terminal components of the complement system 
((25-9).  However, the  mechanism of resistance of gram-negative bacteria to serum 
killing in the presence of adequate antibody is still unknown. 
Resistance to serum killing could involve the inability to form a membrane attack 
complex on the organism. An alternative hypothesis, however, is that  a  membrane 
attack complex  that  forms on  the  bacterial  surface may be functionally  impotent 
either because of failure to insert into the bacterial outer membrane or because the 
inserted complex does not cause damage to vital outer or inner membrane structures. 
Previous studies  have examined  a  number of aspects of this  issue.  Studies  have 
suggested that serum-sensitive and serum-resistant strains of Escherichia coli (9,  10) or 
Salmonella typhimurium  (11) have equivalent amounts of C3 deposited. It is not resolved 
whether (25  is deposited on serum-resistant bacteria.  Reynolds et al.  (11)  could not 
demonstrate deposition  of functional  C5  on serum-resistant S.  typhimurium  in  Mg  ++ 
saline after incubation  in C6-deficient rabbit serum. On the other hand, Ogata and 
Levine (10) demonstrated equivalent (25 consumptior~ by strains of E. coli that varied 
in  complement  sensitivity;  however,  evidence  for levels  of cell-bound  (25  was  not 
1  Abbreviations used in this paper:  CFU,  colony-forming  unit; HBSS, Hanks' balanced salt solution; LPS, 
lipopolysaccharide; PNHS, pooled normal human serum; RT, room temperature. 
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provided. No studies have quantitatively evaluated fixation of terminal complement 
proteins to the bacterial surface of serum-resistant gram-negative bacteria. 
We  examined  the  interaction  of terminal  complement  components  with  serum- 
resistant bacteria in a  systematic fashion. Using highly purified, functionally active, 
radiolabeled complement components, we examined deposition of C3, a  component 
not associated with the terminal attack complex, as well as deposition of C5, C7, and 
C9  (the first, third, and fifth members of the five-member terminal attack complex). 
The results of this study demonstrate that there is no block in complement utilization 
by  these  serum-resistant  organisms.  On  the  contrary,  the  serum-resistant  bacteria 
possess a  unique mechanism allowing them to assemble and shed the intact terminal 
complex without sustaining lethal membrane damage. 
Materials and  Methods 
Buffers.  The following buffers were used: veronal-buffered saline containing 0.1%  gelatin, 
0.15 mM CaC12, and  1.0 mM MgCI~ (VBSG++); Hanks' balanced salt solution (HBSS); and 
HBSS with 0.15 mM CaCI2 and 1.0 mM MgCI~ (HBSS++). 
Bacteria.  Salmonella  minnesota Re595 and S. minnesota $218 were kindly provided by Dr. Jacik 
Hawiger,  Vanderbilt  University,  Nashville, TE.  S.  minnesota $218  is  a  smooth,  wild-type 
organism containing a complete LPS. This organism is reported to be serum resistant (12). S. 
minnesota Re595 is a mutant of the above parent strain. This deep rough mutant contains only 
lipid A and 2-keto 3-deoxy oetonate in the LPS and lacks the remainder of the core polysac- 
eharide and O-specific polysaccharide moieties present in the parent strain (13).  It is reported 
to be highly sensitive to the lytie action of serum (12). 
Bacteria were inoculated from frozen stocks onto GC agar base plates containing horse blood 
and  1% Isovitalex. Plates were incubated overnight at 37°C. Organisms were then inoculated 
into tryptiease sOy broth and incubated for 6-6½ h at 37°C in a rotating rack. Bacteria were 
washed two times in HBSS at room temperature (RT)  and suspended to ODs00 =  1.240  in 
HBSS  ++. This optical density corresponded to 1.46 ×  109 colony-forming units (CFU)/ml for 
$218 and 1.12 ×  109 CFU/ml for Re595. 
Serum.  Pooled normal human serum (PNHS) was obtained from  10 volunteers. Antibody 
titers in PNHS to $218 and Re595, measured by bacterial agglutination of 1 ×  109 CFU/ml 
were 1:32 and 1:8, respectively. Sera were obtained from patients with a complete deficiency of 
C2 or C8, and plasma from a patient with complete deficiency of C5 was the kind gift of Dr. 
Henry Gewurz, Rush Medical School, Chicago, IL. 
Serum Bactericidal Test.  Equal volumes of various dilutions of PNHS in HBSS  ++ at 4°C and 
a bacterial suspension adjusted to the desired optical density were mixed in 12 ×  75-ram plastic 
tubes  and  immediately incubated  at  37°C  in  a  water bath with  intermittent  shaking.  At 
varying times thereafter, 30- to 50-#1 samples were removed for quantitative bacterial cultures. 
Aliquots were serially diluted in HBSS, and 40 #1 was plated on GC agar base horse blood 
plates. Colonies were counted after overnight incubation, and results were expressed as logx0 
CFU/ml. The extent of killing was expressed as loglo kill, calculated as log~0 CFU/ml in heat- 
inactivated serum minus log10 CFU/ml in unheated serum. 
Ab Preparation and Presensitization.  Antibody to Re595  and  $218  was raised in  rabbits as 
previously described (14). Immunoglobulin-containing fractions containing IgM and IgG were 
prepared by 5% polyethylene glycol precipitation and octanoie' add precipitation. Antibody 
titers  of immune  rabbit  serum  or  immunoglobulin  fractions  were  measured  by  bacterial 
agglutination at 4°C using 1 ×  109 CFU/ml of viable organisms or at RT using an equivalent 
number of heat-killed organisms. Titers of immune serum were  1:128  for $218 and  1:32  for 
Re595. Titers of immunoglobulin fractions were 1:512 for $218 and  1:256 for Re595. Bacteria 
were presensitized in some experiments by incubation of 6  ×  109 CFU of Re595  or 7 ×  10  s 
CFU of $218 with either 4 ml of heated immune rabbit sera diluted 1:32 for Re595 and 1:128 
for $218 or 4 ml of a  1:512 dilution of the immunoglobulin fraction. Bacteria were incubated 
with antibody for 30 rain at RT and washed twice in HBSS. 
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C7, C8, and C9 was performed with minor modifications, as previously described by Hammer 
et al. (15),  from a  2-liter pool of fresh normal human EDTA-plasma. The C9 was brought to 
homogeneity by chromatography on Biogel A-0.5m, followed by passage over an immunoad- 
sorbent column with antibodies to C4, IgG, IgA, and albumin. Purity of the isolated proteins 
was assessed, in part, by sodium dodecyl sulfate polyacrylamide gel electrophoresis and by 
immunoelectrophoresis in 1.0% agarose. 
Radiolabeling of C3, C5, and C7 with 1~I was performed using Inman's modification of the 
Bohon-Hunter technique (16.)  Radioiodination of C9 with 1251 or ~alI was done by the solid- 
phase glucose oxidase-lactoperoxidase method,  (Enzymobeads, Bio-Rad Laboratories, Rich- 
mond, CA). There was no loss of hemolytic activity of C3, C7, or (29 with labeling, whereas C5 
preparations sustained losses of hemolytic activity of ~15%.  Specific radioactivity of labeled 
components was C3, 5.25  ×  105 cpm/lag; C5, 4.99 X  10  s cpm//Lg; C7, 3.82 ×  10  s cpm/#g; and 
C9, 1.74 x  108 cpm//~g. 
Quantitation of Radiolabeled Component Binding to Bacteria.  Radioiodinated C3, C5, C7, or C9 
were added to diluted serum before mixing with bacteria to attain between 5 ×  105 and 2 X  10e 
cpm/ml. Mixtures of bacteria and serum prepared as described under Serum Bactericidal Test 
were incubated at 37°C. At designated times, 200 #l of reaction mixture was removed, added 
to 1.0 ml of ice-cold HBSS in a  1.5-ml high-speed centrifuge tube, and immediately centrifuged 
for  5  min  at  12,500  g  at  RT  (Eppendorf,  Brinkman  Instruments,  Westbury,  NY).  The 
superuatant was removed by vacuum suction, and the bottom 5 mm of the tube containing the 
bacterial pellet was removed for counting. This method was shown in preliminary experiments 
to give the highest percentage of specific binding of radiolabeled components, calculated as: 
cpm pellet (serum) -  cpm pellet (heat-inactivated serum) 
percent specific binding = 
cpm input 
×  100. 
The cpm in the pellet of heat-inactivated serum mixture was 0.3-0.5% of total input counts. 
Molecules of radiolabeled component bound per CFU were calculated from the specific cpm 
bound  per pellet, the known  original CFU  per pellet, and  the specific radioactivity of the 
labeled component. Total molecules of component bound (labeled plus unlabeled) were then 
derived from the ratio of hemolytic units of unlabeled component to hemolytic units of labeled 
component in the reaction mixture. The ratio of bound C9 to bound C7 was calculated from 
values  for  total molecules of each component  per CFU.  All measurements  of binding of 
radiolabeled components were done in duplicate on at least two occasions. 
This  procedure allows one  to  quantitatively collect lysed as well as unlysed bacteria, as 
determined by an experiment in which the serum-sensitive Re595 organisms were incubated in 
C8D human serum. The uptake of C3, C5, and C7 on these viable bacteria after high-speed 
centrifugation was equivalent to results in normal human serum in which >99% of bacteria 
were killed. 
Consumption of Hemolytic Activity.  Consumption of hemolytic C3, C5, C7, C8, and C9 activity 
in reaction mixtures containing either serum-sensitive or serum-resistant organisms was mea- 
sured. Hemolytic titrations on reaction mixture supernatants were performed within  1 h after 
collection, using the appropriate complement-cellular intermediate at  1.5 ×  10  7 cells (EAC  1, 
4, or EAC  1-7)  in a  total reaction volume of 0.5  ml after minor modifications of standard 
techniques (17). Controls included serum in HBSS  ++ without bacteria, incubated and handled 
concomitantly with the test samples. 
Release of [X4C]Phospholipid from Re595 and $218.  For measurement  of [14C]phospholipid 
release, Re595 and $218 were initially grown overnight in trypticase soy broth (TSB). Then, 
4.5  ml of Tris glucose media (18)  containing 0.03%  glucose and 2 #Ci/ml  [14C]glucose  (329 
mCi/mmol; New England Nuclear, Boston, MA) was added to the pellet from 0.5 ml of the 
averuight TSB broth culture. The organisms were incubated for 4  h  at 37°C, washed three 
times in HBSS, and suspended to OD  =  1.240  in HBSS  ++.  Equal volumes of the bacterial 
suspension and varying concentrations of PNHS diluted in HBSS  ++ were mixed. Samples of 
500 #1 were withdrawn at differing times, the bacterial pellet was sedimented at 12,500 g for 5 
min,  and  the supernatant  was removed.  Lipids were extracted from  some samples by the 
method of Bligh and Dyer (19). Aliquots of 50 #1 were added to 10 ml of Aquasol (New England 800  MECHANISM OF SERUM RESISTANCE IN BACTERIA 
Nuclear)  and counted in  a  beta scintillation  counter (LS8100; Beckman  Instruments,  Inc., 
Fullerton, CA). 
Electron Microscopy.  Bacteria  in Tris  buffer  were negatively  stained  with  2%  ammonium 
molybdate and examined by transmission electron microscopy at 75 Kv in a Hitachi instrument, 
model HU-11C. 
Results 
Serum Susceptibility of S  minnesota Re595 and $218 in PNHS, Adsorbed PNHS, MgEGTA 
Serum, and  C2D  Serum.  Initial  experiments  examined  the  serum  sensitivity  of S. 
minnesota strains.  S.  minnesota $218 was resistant  to killing by normal human serum 
after incubation for  1 h  at  37°C at serum  dilutions between 0.31  and 40%;  colony 
counts decreased by only 20% when $218 was incubated in 80% PNHS. In addition, 
there was no killing in 10% PNHS in three different buffer systems (HBSS  ++, VBSG  ++, 
and 0.05  M  or 0.1  M  Tris).  S.  minnesota Re595 bacterial  lysis  in  PNHS followed a 
sigmoidal curve when plotted as log kill  vs. percent serum  (Fig.  1).  In  10%  PNHS, 
99.9%  of bacteria were killed (log killing :1: SD in  10% PNHS was 2.84:1:0.26 in 23 
separate  experiments).  Presensitization  of $218 with  immune rabbit  serum  or with 
purified immune IgG and IgM for 30 min at RT, followed by washing and incubation 
with  10% PNHS for 60 min did not result in serum sensitivity. Killing of Re595 was 
decreased 20-30% in  10% PNHS, which was pre-adsorbed with 2.5  ×  10  l° CFU/ml 
serum  for 30 min at 0°C, suggesting that antibody augments killing of the serum- 
sensitive strain.  Log killing of Re595 was 0.29 in  10% PNHS containing MgEGTA, 
0.19 in C2D serum, and was almost  100-fold less than killing in  10% PNHS (2.45). 
These experiments confirm that $218 is resistant  to killing by normal human serum 
in the presence of antibody (12) and show that the killing of Re595 in human serum 
is mediated predominantly by the classical complement pathway under these condi- 
tions. 
Consumption of C3 in PNHS.  The kinetics of C3 consumption was studied at three 
concentrations  of serum:  2.5,  10,  and  40%.  Shown  in  Fig.  2  are  the  kinetics  of 
consumption in  10%  serum.  The  kinetics  were  similar  at  each  of the  three  serum 
concentrations  examined.  Consumption  of C3  proceeded  rapidly  and  essentially 
reached an endpoint at  15-20 min with ~80% consumption of C3 in  10% PNHS. 
Uptake of tz~IC3 on  Re595  and $218  in  PNHS.  The  kinetics  of radiolabeled  C3 
uptake on the bacterial surface was also examined in 2.5,  10, and 40% serum over a 
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FIG.  1.  Killing of S. minnesota Re595 and S. minnesota $218 by PNHS. Bacteria at a concentration 
of 5.6 X l0  s cells/ml (Re595) or 7.3 X 10  a cells/ml ($218) were incubated for60 min at 37°C in 
dilutions of PNHS ranging from 0.31 to 80%. Re595 (0"''"-0); $218 (A  A). JOINER  ET  AL. 
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Flo.  2.  Consumption and uptake of C3 by S. minnesota Re595 and S. minnesota $218 in 10% PNHS. 
Bacteria at a concentration of 5.6 X 10  s cells/ml (Re595) or 7.3 x  l0  s cells/ml ($218) were incubated 
in 10% PNHS in HBSS  ++ containing a25I C3. The control tube for C3 consumption contained 10% 
PNHS  in  HBSS  ++  without  bacteria.  Control  tubes  for  1~I  C3  binding  contained  10%  heat- 
inactivated PNHS in HBSS  ++ and either Re595 or $218 at the above concentration. Samples were 
removed at the designated times for measurement of C3 consumption and specific x25I C3 binding, 
and total molecules  of C3 bound per CFU were calculated. All values for C3 consumption were 
expressed relative to the control tube at each time. All experiments were repeated at least twice, and 
values between experiments did not vary by >10%.  For C3 consumption, Re595  (C)---O), $218 
(A- - -A); for C3 binding, Re595  (H),  $218 (A  A). 
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Fro.  3.  Consumption of C5, C7, and C9 by S. minnesota Re595 and S. minnesota $218 in 10% PNHS. 
Experimental conditions were as outlined in the legend to Fig. 2, except that  10% PNHS did not 
contain ~I C3. All values for percent consumption were expressed  relative to the control tube at 
each time. Re595:C5  (D- - -[[3), C7 (C)  O), C9 (A  .... A); $218:C5 ~  - -~,  C7 (H), 
C9 (&  ..... &). 
60-min period of incubation  at  37°C.  Results for  10% serum are shown in Fig. 2, but 
kinetics were similar in  2.5%  and  40%  serum.  Uptake  of 125I C3 by  Re595  and  $218 
in  PNHS  was  rapid  and  plateaued  at  a  peak  value  for both  organisms  by  20  min. 
Twice as many  molecules of C3 were bound  per CFU  of serum-resistant  $218 as were 
bound  per CFU  of serum-sensitive Re595  in  10% PNHS. 
Consumption  of C5, C7, and C9 by Re595 and $218.  Consumption  of C5, C7, and  C9 
was examined in kinetic experiments in  10% PNHS  (Fig. 3). No measurable depletion 
of C5,  10%  C7  consumption,  and  26%  depletion  of C9  occurred  in  the  reactions 
containing  the  serum-sensitive  organisms  and  10%  PNHS.  In contrast,  depletion  of 
C5  and  C7  in  the  reaction  of $218  and  10%  PNHS  approached  95%  by  15  min  of 
incubation,  and  complete inactivation  of hemolytic C9 was observed  by 5  min.  The 
kinetics  of C9  consumption  were  also  examined  in  2.5%  and  40%  serum  and  were 
equivalent  to  those  in  10%  serum.  No  loss  of C9  hemolytic  activity occurred  when 802  MECHANISM  OF  SERUM  RESISTANCE  IN  BACTERIA 
$218 was incubated in PNHS containing 0.01  M  EDTA or in 10% C5D serum (Table 
I). Addition of purified C5 to C5D serum restored the ability of $218 to consume C9. 
Complete inactivation of C9 occurred when heat-killed, washed $218 organisms were 
incubated in 10% PNHS. These experiments demonstrated that inactivation of C9 by 
$218  was  dependent  on  complement  activation  and  was  independent  of bacterial 
viability. Complete consumption of terminal complement components by $218 dem- 
onstrates that serum resistance does not result from a block in complement activation. 
Uptake of 1~I C5, 1~I C7, and 125I C9 on Re595 and $218.  The kinetics of deposition 
of  terminal  complement  components  on  the  serum-resistant  and  serum-sensitive 
organisms  in  10%  PNHS  was  studied  next  (Fig.  4).  Binding  of C5,  C7,  and  C9 
increased rapidly and progressively on serum-sensitive Re595. The maximum specific 
TABLE  I 
Consumption of C9 by S. minnesota 218 and S. minnesota Re595" 
Re595  $218 
%  % 
10% PNHS  29  100 
10% PNHS in 0.01 M  EDTA  1 !  4 
10% C5D  0  0 
10% C5D +  9640 U/ml C5  22  88 
10% PNHS~:  20  98 
* Percent  of hemolytic activity consumed after 60-min incubation  at  37°C; 
consumption calculated relative to control tubes without bacteria incubated 
concomittantly. 
:]: Heat-killed bacteria (80°C for 10 min). 
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Fxo.  4.  Binding of C5, C7, and C9 on S. minnesota  Re595 and 
S.  minnesota $218  in  10%  PNHS.  Experimental conditions 
were  as outlined in  the legend  to  Fig.  2,  except  that  10% 
•  125  PNHS and I0% heated serum contained eRher  I C5 (Fig. 
4 A), t25I C7 (Fig. 4 B), or x2sI C9 (Fig. 4 C). Total molecules 
bound were calculated as described in Materials and Meth- 
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uptake of labeled C5, C7, and C9 was  1.9%,  1.3%, and 5.1% on Re595.  In contrast, 
maximum binding of C5, C7, and C9 on the serum-resistant $218  was  7.6%, 4.2%, 
and 2.4%.  Surprisingly, binding of C5, C7, and C9 on the serum-resistant organism 
reached a  peak at  5-10 min. Thereafter, progressive and striking loss of the bound 
components from $218  was observed with continued  incubation.  Release of 125I  C9 
from $218 was also demonstrated when heat-killed $218 was studied, demonstrating 
that loss of lzsI C9 from the bacterial surface was not a  function of bacterial growth 
or metabolism. 
These experiments demonstrate that the serum-sensitive organism consumes rela- 
tively small amounts of C5, C7,  and C9,  and these components are efficiently and 
stably deposited  on the bacterial surface.  In contrast,  all of the C5,  C7,  and C9  is 
consumed  in  the  reaction  with  the  serum-resistant  organism.  Binding  of terminal 
components is less efficient than with the sensitive organism, and components are not 
stably bound to the bacterial surface. 
Uptake of l~I C7 and t~l I  C9 on Re595 and $218.  Experiments with l~I-labeled C5, 
C7, and C9 suggested that fewer molecules of C9 were bound per bound molecule of 
C5 or C7 on $218  than on Re595. This was examined in a  double-label experiment 
using uptake of 131I C9 and 125I C7. An average of 4.3  C9:C7  was bound to serum- 
sensitive Re595 by 15 min, but the ratio ofC9:C7 on $218 was 0.68. The ratios remain 
constant during the remainder of the incubation, indicating that C7 and C9 on $218 
were being released at the same rate. Because C9 was totally consumed in the reaction 
of 10% PNHS and $218, the possibility that addition of excess C9 would increase the 
ratio of C9:C7  on $218  was investigated.  Unlabeled  C9 in  increasing amounts was 
added  to  10% PNHS to achieve final C9 titers ranging from 4,000  U/ml to  14,000 
U/ml.  Binding  of lalI C9  and  125I C7  was  measured,  and  the  ratio  of C9:C7  was 
calculated  (Fig. 5). A  linear decrease in 131I C9 molecules bound per CFU of Re595 
was observed as the concentration  of C9 increased  (Fig.  5 A), but  no change in the 
ratio of total C9 to C7 molecules bound occurred (Fig. 5 B). This demonstrates that 
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FIef.  5.  (A) Molecules lslI C9 bound/CFU of S. minnesota Re595 or S. minnesota $218 in 10% PNHS 
with addition of purified, unlabeled C9 at t  =  0. Bacteria at a  concentration of 5.6 ×  108 eells/ml 
(Re595)  or  7.3  ×  108 cells/ml  (8218)  were incubated  in  10%  PNHS  (C9 titer  =  4,000  U/ml)  in 
HBSS  ÷÷ containing ]2sI C7 and XalI C9 and also containing an additional 0, 2.5 ×  103, 5 X  l0  s, 7.5 
×  103, or 1.0 ×  104 U/ml of purified, unlabeled C9 added at t =  0. Molecules of 125I C7 and laaI C9 
bound  per  CFU  were  measured  after  incubation  for  30  rain  at  37°C.  Re595  (0----0);  $218 
(i  A). (B) Ratio of (29 molecules bound per C7 molecules bound on S. minnesota Re595 and S. 
minnesota $218 from part 5 A. Re595  (0- -  -0); $218 (i  i). Total molecules of C9 and C7 were 
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TABLE  II 
Release of t4C from S. minnesota Re595 and S. minnesota $218 after 
Incubation in  Varying Dilutions of PNHS 
Percent 
PNHS 
Percent total a4C released*  Percent [14C]lipid  released:J: 
Re595  $218  Re595  $218 
% 
5  21.4 ::t::  5.3  1.7 +  1.3  10.0 +  1.6  2.5 + 0.5 
10  32.0 + 5.9  3.5 ::l:  0.4  21.1 ::t: 1.8  4.1 + 0.8 
20  54.7 "¢- 1.9  6.4 ::1: 1.4  33.9 ::tz  4.3  4.7 + 0.7 
Bacteria were prepared as described in Materials and Methods and incubated 
for 60 min  in dilutions of PNHS. Total 14C release and [14C]lipid release, 
using the method of Bligh and Dyer (17), were measured. Results shown are 
mean :1: SD for two experiments done in duplicate. 
* 14C released per total x*C in reaction mixture. 
:]: [a4C] lipid released per total [14C]lipid  in reaction mixture. 
(a)  the  maximum  achievable ratio of C9:C7  on  Re595  is 4.3:1,  and  (b)  the  13xi C9 
molecules  behave  like  unlabeled  C9  molecules.  The  latter  finding  is  a  necessary 
condition for validity of calculation of total molecules of C9 bound. In contrast, with 
increasing inputs of C9, there was no change in molecules 131I C9 bound to $218  (Fig. 
5 A), and  the  C9:C7  ratio  increased  from  0.68  to  3.3  (Fig.  5 B).  In  a  separate but 
otherwise identical experiment (not shown), up to 25,000 U/ml  of unlabeled C9 was 
added to the reaction mixture with $218,  and the C9:C7  ratio reached 4.4:1. There 
was no difference in the rate of release of 12sI C7 or 13aI C9 from  $218  as the C9:C7 
ratio increased. 90% consumption of C9 by $218 occurred at the highest concentration 
of added C9  in Fig. 5 A  (10,000  U/ml).  Therefore,  the low C9:C7  ratio on  $218  in 
10%  PNHS  does not  represent a  defect in the capacity of C5b678  on  the surface of 
$218 to bind multiple C9 molecules, but rather reflects depletion of C9 from the fluid 
phase. Even at the highest ratio ofC9:C7 achieved, no killing of $218 occurred in any 
of the tubes. 
Release  of 14C from  Re595  and  $218.  Experiments  measuring  release  of 14C  from 
Re595  and  $218  by  PNHS  provided  evidence  that  C5b-9  does  not  substantially 
damage the outer membrane of the serum-resistant organism. The percentage of t4C 
released from Re595 was  10 times higher than from $218 at all serum dilutions tested 
(Table II). Only 3.5% of 14C was released from $218 in  10% PNHS. However, smooth 
gram-negative bacteria contain  a  smaller amount  of outer membrane  phospholipid 
than  rough organisms, and  this factor might  influence the above results. Therefore, 
the percent of total  [14C]lipid released was also measured  as described in Materials 
and Methods.  As shown  in Table II, only 4.1% of total [14C]lipid was released from 
$218 in  10%  PNHS, compared with 21.1% release from Re595.  These results suggest 
that C5b-9 on $218 neither disrupts the outer membrane nor releases outer membrane 
lipids. 
Electron  Microscopy.  The  serum-sensitive  Re595  and  serum-resistant  $218  were 
examined by electron microscopy after incubation of the organisms in  10% PNHS  for 
30 min  (Fig. 6).  Extensive spheroplast formation and outer membrane damage with 
bleb formation was apparent for Re595.  No evidence of outer membrane damage or 
spheroplast formation was noted for $218. JOINER  ET  AL.  805 
FIG. 6.  Transmission  electron  microscopy  of  S.  minnesota  Re595  and  S.  minnesota  $218  after 
incubation in 10% PNHS.  (A) Re595; magnification, ×  48,000.  (B) $218; magnification, ×  48,000. 
Discussion 
Relative serum resistance is an important factor in determining the virulence of a 
number of gram-negative organisms. These experiments explore the molecular basis 
of such serum resistance using two closely related strains of S.  minnesota.  Our initial 
experiments  confirmed  earlier  observations  (12)  that  S.  minnesota  $218  is  highly 
resistant to the lytic action of serum, whereas Re595 is highly sensitive. Our studies 
demonstrated that both organisms consume C13 from serum and that x25I C3 uptake 
parallels  consumption.  Twice as  many molecules of C3  are bound  to  $218  as  are 
bound to Re595. Once bound, the C3b binding appears stable during the period of 
observation. 
Interestingly, there is total consumption of C5, C7, and C9 by the serum-resistant 
organism,  but  there is  minimum  consumption of these components by the serum- 
sensitive  strain.  This  is  reflected in  kinetic  experiments  by  a  high  initial  rate  of 
consumption of C5,  C7,  and  C9  on  the  serum-resistant  strain.  These experiments 
proved that consumption of late components was associated with  activation of the 
complement cascade and that  bacterial  proteases were not  released that  destroyed 
critical  complement  components  in  the  fluid  phase.  It  was  also  essential  to  study 
uptake of components on the bacterial surface because consumption of components 
in the fluid phase could have been mediated by released fragments of the bacterial 
outer membrane. Total depletion of terminal components in the fluid phase would 806  MECHANISM  OF  SERUM  RESISTANCE  IN  BACTERIA 
have prevented bacterial killing and lysis.  However, our results showed that C5, C7, 
and  C9  were  rapidly  bound  to  $218  with  maximum  uptake  by  5-10  min,  but 
thereafter a progressive loss of all components occurred from the bacterial surface. In 
contrast, binding of C5, C7, and C9 to Re595 was stable and was  associated with 
minimum consumption of these components. 
Experiments using a2sI C7 and lalI C9 in  10% PNHS demonstrated that the ratio 
of C9:C7  on  Re595 was  4.3:1  but was <l:l  for $218.  However, experiments with 
addition of unlabeled exogenous C9 to 10% PNHS demonstrated that further incor- 
poration  of C9  can  occur on  the  surface  of $218.  In  this  case,  the  C9:C7  ratio 
approached the ratio of 4.3:1  observed on Re595. Because consumption of C9 was 
essentially complete at all concentrations of added C9, this suggests that availability 
of hemolytically  active  C9  is  the  limiting  factor  in  the  C9:C7  ratio  on  $218. 
Nonetheless, even when  the  C9:C7  ratio on  $218  was  equivalent  to  the  ratio  on 
Re595, no killing of $218 occurred. Current evidence suggests that one molecule of 
C5, C6, C7, and C8 combines with three to six molecules of C9 for both the fluid- 
phase human SC5b-9 and dimeric human membrane attack complex (20, 21). Thus, 
our results are in general agreement with published data, although, because of the 
differences in methodology and in the membranes studied, the results may not  be 
directly comparable. 
Release of phospholipids from the cell membrane of serum-sensitive gram-negative 
bacteria by the action of complement has been demonstrated repeatedly (22,  23). 
Such release is consistent with the amphiphilic nature of the C5b-9 complex, which 
is capable of binding and  releasing phospholipids from lipid vesicles, erythrocytes, 
and serum-sensitive gram-negative bacteria. Beckerdite-Quagliota et al. demonstrated 
that phospholipids were not released from a serum-resistant strain of Serratia marcesens, 
but  substantial  phospholipid  release  occurred  from  a  serum-sensitive  strain  of S. 
marcesens (24). This finding is similar to the results of our studies and suggests that the 
amphiphilic C5b-9 on $218 does not interact with membrane phospholipids. 
The results presented here suggest that serum resistance of S.  minnesota  $218 does 
not represent a  defect in membrane attack complex formation on the surface of the 
organism. Rather, the formed complex does not remain associated with the bacterial 
surface, suggesting that the complex does not insert firmly into the outer membrane. 
Summary 
The mechanism of resistance of gram-negative bacteria to killing by complement 
was  investigated.  Complement  consumption  and  uptake  of purified,  radiolabeled 
complement components on bacteria was studied using a serum-sensitive and a serum- 
resistant strain of Salmonella minnesota.  Twice as many molecules of 1~I C3 were bound 
per colony-forming unit  (CFU)  of the smooth, serum-resistant S.  minnesota  $218 as 
were bound per CFU of the rough, serum-sensitive S.  minnesota  Re595 in  10% pooled 
normal  human  serum  (PNHS),  although  75-80%  of C3  was  consumed  by  both 
organisms. Hemolytic titrations documented total consumption of C9 by 5 min and 
>95%  consumption of C5  and C7  by  15 min in  the reaction with  $218 with  10% 
PNHS. In contrast, negligible C5  depletion,  10% C7 consumption, and only a  26% 
decrease in C9 titer occurred with the serum-sensitive Re595. Binding of 125I C5, a25I 
C7, and  126I C9 to S218 and Re595 was measured in  10% PNHS. A  total of 6,600 
molecules C5/CFU, 5,200 molecules C7/CFU, and 3,100 molecules C9/CFU bound JOINER ET AL.  807 
to $218 after 5-10 min of incubation at  37°C, but 50-70% of the C5, C7, and C9 
bound to $218 was released from the organism during incubation at 37°(2 for 60 rain. 
Binding of 2,000 molecules C5/CFU, 1,900 molecules C7/CFU, and 9,000 molecules 
C9/CFU to Re595 was achieved by 20 min and was stable. The ratio of bound C9 
molecules to bound C7 molecules, measured using lalI C9 and 1~I C7, was constant 
for both organisms after  15 min and was 4.3:1 on Re595 and 0.65:1 on S218 in  10% 
PNHS. With addition of increasing amounts of purified, unlabeled (29 to 10% PNHS, 
there was no change in the C9:(27 ratio on Re595. However, with $218 there was a 
linear increase of the C9:C7 ratio, which approached the ratio on Re595. There was 
no 14(2 release  from $218 incubated  in  PNHS, nor was there evidence by electron 
microscopy of outer  membrane  damage  to  $218.  Therefore,  S.  minnesota  $218  is 
resistant  to killing by PNHS, despite the fact that the organism consumes terminal 
complement components efficiently and that terminal components are deposited on 
the surface in significant amounts. The C5b-9 complex is released from the surface of 
$218 without causing lethal outer membrane damage. 
The authors would like to acknowledge the excellent editorial  assistance of Karen Leighty in 
preparation of this manuscript. 
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